British American Tobacco Announces Extension Of Share Buyback

British American Tobacco said it will extend the share buyback programme announced on March 18, 2024, by up to £1.3 billion for 2026, entering an irrevocable, non-discretionary agreement with UBS AG London Branch to execute the next tranche of purchases. The tranche is expected to be completed during the company’s closed period from Jan. 2 to Feb. 11, 2026, and UBS will make trading decisions independently of BAT. The extension represents a continued capital return to shareholders and ensures buybacks will be executed through an independent broker during the blackout period.

Analysis

British American Tobacco announced an extension of its share buyback programme first disclosed on 18 March 2024, adding up to £1.3 billion for 2026 and signing an irrevocable, non-discretionary agreement with UBS AG London Branch to execute the next tranche. The tranche is expected to be completed during the company’s closed period from 2 January 2026 to 11 February 2026, and UBS will make trading decisions independently of BAT. Market signal outputs classify the news as mildly positive (sentiment_score 0.28, market_impact_score 0.3) with per-ticker sentiment for BTI at 0.5, reflecting a modestly bullish investor reaction. Independent execution via UBS reduces governance and insider-trading concerns and ensures buyback activity proceeds despite the blackout window.

The announced extension reinforces BAT's priority on capital returns and should mechanically reduce shares outstanding when executed, supporting EPS and cash-return metrics absent other changes. Timing the tranche during the closed period concentrates execution into early-2026, which could amplify price impact and short-term volatility around the execution window; investors should therefore watch official completion disclosures. The structured nature of the agreement and the explicit broker independence limits corporate intervention risk but does not eliminate market execution risk tied to timing and liquidity conditions.

Key Decisions for Investors

• Consider maintaining or modestly increasing exposure to BTI as the £1.3 billion buyback extension is a shareholder-return positive and is likely to support EPS when completed,
• Monitor buyback execution details, share-count updates and price/volume activity during the announced closed period (2 Jan–11 Feb 2026); use announced completion notices as key catalysts for rebalancing positions,
• Employ tactical hedges or option strategies to capture potential upside from buyback-driven support while protecting against concentrated execution risk and short-term volatility around the delivery window